Notice of Meeting, 13302-13303 [2022-04910]

Download as PDF 13302 Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special Emphasis Panel; Review of Neurosurgeon K12 Applications. Date: April 5, 2022. Time: 4:00 p.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Virtual Meeting). Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, NINDS, NIH, NSC, 6001 Executive Boulevard, Suite 3204, MSC 9529, Bethesda, MD 20892–9529, 301–496–0660, benzingw@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: March 3, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–04943 Filed 3–8–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jspears on DSK121TN23PROD with NOTICES1 National Heart, Lung, and Blood Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Sleep Disorders Research Advisory Board. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Sleep Disorders Research Advisory Board. Date: April 7, 2022. Time: 12:00 p.m. to 5:00 p.m. Agenda: The purpose of this meeting is to update the Advisory Board and public VerDate Sep<11>2014 17:44 Mar 08, 2022 Jkt 256001 stakeholders on the progress of sleep and circadian research activities across NIH, and the activities of Federal stakeholders and professional societies. Place: Virtual Meeting. Telephone Access: 1–666–254–5252 (Meeting ID: 161 532 8417 Passcode: 330488). Virtual Access: https://nih.zoomgov.com/s/ 1615328417?pwd=Wm52ZmZFMDVa RWE4bGVsOTcrSW1UUT09. Contact Person: Marishka Brown, BS, MS, Ph.D., Health Scientist Administrator, National Center on Sleep Disorders Research, National Heart, Lung, and Blood Institute, National Institute of Health, 6705 Rockledge Drive, Bethesda 20814–7952, 301–435–0199, ncsdr@nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: www.nhlbi.nih.gov/meetings/ index.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Promoting Bunyavirales Basic Science Research (R01 Clinical Trial Not Allowed). Date: April 5–6, 2022. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E72A, Rockville, MD 20892 (Virtual Meeting). Contact Person: Frank S. De Silva, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E72A, Rockville, MD 20852, (240) 669–5023, fdesilva@ niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: March 3, 2022. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2022–04942 Filed 3–8–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: March 4, 2022. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. Substance Abuse and Mental Health Services Administration [FR Doc. 2022–04982 Filed 3–8–22; 8:45 am] Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Treatment (CSAT) National Advisory Council (NAC) will meet on April 27, 2022, 1:00 p.m.–4:30 p.m. (EDT). The meeting is open to the public and will include consideration of minutes from the SAMHSA CSAT NAC meeting of August 12, 2021, and a discussion with SAMHSA leadership. It will also cover updates on CSAT activities from the Office of the Director (OD); the Division of Pharmacologic Therapies (DPT); the State Opioid Response Program (SOR); the Division of State BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Notice of Meeting E:\FR\FM\09MRN1.SGM 09MRN1 Federal Register / Vol. 87, No. 46 / Wednesday, March 9, 2022 / Notices and Community Assistance (DSCA); the Division of Services Improvement (DSI), and a discussion on substance use disorder and oral health. The meeting will be conducted via Zoom and telephone only and registration is required to participate. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations must notify the contact person, Tracy Goss, CSAT NAC Designated Federal Officer (DFO) on or before April 15, 2022. Up to three minutes will be allotted for each approved public comment as time permits. Written comments received in advance of the meeting will be considered for inclusion in the official record. To attend virtually, submit written or brief oral comments, or request special accommodation for persons with disabilities, please register on-line at https://snacregister.samhsa.gov/ MeetingList.aspx, or communicate with the CSAT NAC DFO (see information below). Meeting information and a roster of Council members may be obtained by accessing the SAMHSA Committee website at https://www.samhsa.gov/ about-us/advisory-councils/csatnational-advisory-council, or by contacting the DFO. Council Name: SAMHSA’s Center for Substance Abuse Treatment, National Advisory Council Date/Time/Type: April 27, 2022, 1:00 p.m.–4:30 p.m. EDT, Open Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857 Contact: Tracy Goss, Designated Federal Officer, CSAT National Advisory Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), Telephone: (240) 276–0759, Email: tracy.goss@ samhsa.hhs.gov Dated: March 2, 2022. Carlos Castillo, Committee Management Officer, SAMHSA. jspears on DSK121TN23PROD with NOTICES1 [FR Doc. 2022–04910 Filed 3–8–22; 8:45 am] BILLING CODE 4162–20–P VerDate Sep<11>2014 17:44 Mar 08, 2022 Jkt 256001 DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection [1651–0092] Application for Withdrawal of Bonded Stores for Fishing Vessels and Certificate of Use (CBP Form 5125) U.S. Customs and Border Protection (CBP), Department of Homeland Security. ACTION: 60-Day notice and request for comments; extension of an existing collection of information. AGENCY: The Department of Homeland Security, U.S. Customs and Border Protection will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 (PRA). The information collection is published in the Federal Register to obtain comments from the public and affected agencies. DATES: Comments are encouraged and must be submitted (no later than May 9, 2022) to be assured of consideration. ADDRESSES: Written comments and/or suggestions regarding the item(s) contained in this notice must include the OMB Control Number 1651–0092 in the subject line and the agency name. Please use the following method to submit comments: Email. Submit comments to: CBP_ PRA@cbp.dhs.gov. Due to COVID–19-related restrictions, CBP has temporarily suspended its ability to receive public comments by mail. SUMMARY: FOR FURTHER INFORMATION CONTACT: Requests for additional PRA information should be directed to Seth Renkema, Chief, Economic Impact Analysis Branch, U.S. Customs and Border Protection, Office of Trade, Regulations and Rulings, 90 K Street NE, 10th Floor, Washington, DC 20229–1177, telephone number 202–325–0056 or via email CBP_PRA@cbp.dhs.gov. Please note that the contact information provided here is solely for questions regarding this notice. Individuals seeking information about other CBP programs should contact the CBP National Customer Service Center at 877–227–5511, (TTY) 1–800–877–8339, or the CBP website at https://www.cbp.gov/. SUPPLEMENTARY INFORMATION: CBP invites the general public and other Federal agencies to comment on the proposed and/or continuing information collections pursuant to the Paperwork Reduction Act of 1995 (44 U.S.C. 3501 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 13303 et seq.). This process is conducted in accordance with 5 CFR 1320.8. Written comments and suggestions from the public and affected agencies should address one or more of the following four points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) suggestions to enhance the quality, utility, and clarity of the information to be collected; and (4) suggestions to minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. The comments that are submitted will be summarized and included in the request for approval. All comments will become a matter of public record. Overview of This Information Collection Title: Application for Withdrawal of Bonded Stores for Fishing Vessels and Certificate of Use. OMB Number: 1651–0092. Form Number: CBP Form 5125. Current Actions: Extension without change of an existing information collection. Type of Review: Extension (without change). Affected Public: Carriers. Abstract: CBP Form 5125, Application for Withdrawal of Bonded Stores for Fishing Vessel and Certificate of Use, is used to request the permission of the CBP port director for the withdrawal and lading of bonded merchandise (especially alcoholic beverages) for use on board fishing vessels involved in international trade. The applicant must certify on CBP Form 5125 that supplies on board were either consumed, or that all unused quantities remain on board and are adequately secured for use on the next voyage. CBP uses this form to collect information such as the name and identification number of the vessel, ports of departure and destination, and information about the crew members. The information collected on this form is authorized by 19 U.S.C. 1309 and 1317 and is provided for by 19 CFR 10.59(e) and 10.65. CBP Form 5125 is accessible at: https://www.cbp.gov/ newsroom/publications/ forms?title=5125. E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 87, Number 46 (Wednesday, March 9, 2022)]
[Notices]
[Pages 13302-13303]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04910]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Treatment (CSAT) National Advisory Council 
(NAC) will meet on April 27, 2022, 1:00 p.m.-4:30 p.m. (EDT).
    The meeting is open to the public and will include consideration of 
minutes from the SAMHSA CSAT NAC meeting of August 12, 2021, and a 
discussion with SAMHSA leadership. It will also cover updates on CSAT 
activities from the Office of the Director (OD); the Division of 
Pharmacologic Therapies (DPT); the State Opioid Response Program (SOR); 
the Division of State

[[Page 13303]]

and Community Assistance (DSCA); the Division of Services Improvement 
(DSI), and a discussion on substance use disorder and oral health.
    The meeting will be conducted via Zoom and telephone only and 
registration is required to participate. Interested persons may present 
data, information, or views, orally or in writing, on issues pending 
before the Council. Presentations from the public will be scheduled at 
the conclusion of the meeting. Individuals interested in making oral 
presentations must notify the contact person, Tracy Goss, CSAT NAC 
Designated Federal Officer (DFO) on or before April 15, 2022. Up to 
three minutes will be allotted for each approved public comment as time 
permits. Written comments received in advance of the meeting will be 
considered for inclusion in the official record.
    To attend virtually, submit written or brief oral comments, or 
request special accommodation for persons with disabilities, please 
register on-line at https://snacregister.samhsa.gov/MeetingList.aspx, 
or communicate with the CSAT NAC DFO (see information below).
    Meeting information and a roster of Council members may be obtained 
by accessing the SAMHSA Committee website at https://www.samhsa.gov/about-us/advisory-councils/csat-national-advisory-council, or by 
contacting the DFO.

Council Name: SAMHSA's Center for Substance Abuse Treatment, National 
Advisory Council
Date/Time/Type: April 27, 2022, 1:00 p.m.-4:30 p.m. EDT, Open
Place: SAMHSA, 5600 Fishers Lane, Rockville, Maryland 20857
Contact: Tracy Goss, Designated Federal Officer, CSAT National Advisory 
Council, 5600 Fishers Lane, Rockville, Maryland 20857 (mail), 
Telephone: (240) 276-0759, Email: [email protected]

    Dated: March 2, 2022.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2022-04910 Filed 3-8-22; 8:45 am]
BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.